Oct 16 (Reuters) – Iovance Biotherapeutics Inc: * IOVANCE BIOTHERAPEUTICS REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4) Source text: Further company coverage:
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Oct 16 (Reuters) - Celanese Corp: * CELANESE CORP - ANNOUNCES GLOBAL PRICE INCREASES FOR…
By Tim Hepher Oct 16 (Reuters) - Boeing jetliner sales chief Brad McMullen is retiring…
SAO PAULO, Oct 16 (Reuters) - Meta employees acknowledged in internal communications that the Instagram…
* Teacher in classroom fought with shooter, saving lives, police say * Shooter, 16, killed…
VIDEO SHOWS: RECENT MANCHESTER UNITED TRAINING FOOTAGE WITH FOCUS ON DEFENDER LISANDRO MARTINEZ / PRESS…
(In paragraph 13, corrects years to 2026, not 2025) By Noel Randewich and Purvi Agarwal…